BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22340717)

  • 1. Role of the JNK pathway in human diseases.
    Sabapathy K
    Prog Mol Biol Transl Sci; 2012; 106():145-69. PubMed ID: 22340717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
    Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
    Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.
    Karin M; Gallagher E
    IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK pathway: diseases and therapeutic potential.
    Cui J; Zhang M; Zhang YQ; Xu ZH
    Acta Pharmacol Sin; 2007 May; 28(5):601-8. PubMed ID: 17439715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
    Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
    Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
    Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
    Sharfi H; Eldar-Finkelman H
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S; Levy G; Hanoch T; Naor Z; Seger R
    Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
    Chen L; Liu L; Yin J; Luo Y; Huang S
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, Cas, and paxillin, formation of Cas-CRK complex, and JNK activation.
    Goel HL; Dey CS
    Differentiation; 2002 Aug; 70(6):257-71. PubMed ID: 12190987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
    Chung J; Chavez PR; Russell RM; Wang XD
    Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage.
    Waetzig V; Herdegen T
    Trends Pharmacol Sci; 2005 Sep; 26(9):455-61. PubMed ID: 16054242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological roles of SAPK/JNK signaling pathway.
    Nishina H; Wada T; Katada T
    J Biochem; 2004 Aug; 136(2):123-6. PubMed ID: 15496581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin gene expression in aortic regurgitation: relative roles of mitogen-activated protein kinases.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Ene AR; Herrold EM; Dumlao TF; Beltran F; Borer JS
    Cardiology; 2009; 113(4):291-8. PubMed ID: 19299894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.
    Johnson GL; Lapadat R
    Science; 2002 Dec; 298(5600):1911-2. PubMed ID: 12471242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.